Genetic Engineering News Arena weight-loss drug caused heart trouble San Francisco Chronicle Arena Inc. said lorcaserin, the weight-loss drug rejected last month, boosted the risk for obese diabetics of a heart abnormality that was among the reasons ... FDA Denied Weight Loss Drug May Be Beneficial to Diabetics HealthNews Arena, Eisai: Lorcaserin produced weight loss in Type 2 diabetics during trial Drug Store News Arena Reports Phase III Data to Help Address Nonapprovable Status of Weight .. Read more »
FDA Denied Weight Loss Drug May Be Beneficial to Diabetics – HealthNews
Genetic Engineering News FDA Denied Weight Loss Drug May Be Beneficial to Diabetics HealthNews While the Food and Drug Administration (FDA) has yet to approve one of the three new weight-loss drugs on their agenda, one of the recently ... Arena, Eisai: Lorcaserin produced weight loss in Type 2 diabetics during trial Drug Store News Arena Reports Phase III Data to Help Address Nonapprovable Status of Weight .. Read more »
Arena Reports Phase III Data to Help Address Nonapprovable Status of Weight … – Genetic Engineering News
Genetic Engineering News Arena Reports Phase III Data to Help Address Nonapprovable Status of Weight ... Genetic Engineering News One of the reasons cited was that the weight-loss efficacy of lorcaserin in overweight and obese individuals without type 2 diabetes was marginal. Read more »
Reading food labels, combined with exercise, can lead to weight loss – Genetic Engineering News
Reading food labels, combined with exercise, can lead to weight loss Genetic Engineering News Previous research has focused on food marketing and behaviour but has not followed related weight loss over time in this middle-aged demographic group. .. Read more »
